Garrigues acts for Qiagen on €118m STAT-Dx acquisition

Garrigues advised Qiagen on the acquisition of STAT-Dx, a Spanish healthcare company that develops diagnostics for analysing diseases and infections.


The deal was valued at €118 million, according to Mergermarket.

A Qiagen statement said: “The acquisition is expected to be completed in the second quarter of 2018 and funded from existing cash reserves.”

STAT-Dx has developed a system, to be branded QIAstat-Dx, that enables processing of up to 48 molecular targets simultaneously to diagnose syndromes such as serious respiratory or gastrointestinal infections.

In 2018, sales of about $7 million are expected from the QIAstat-Dx launch in “Europe and other markets”, while sales of at least $30 million are expected in 2019, the Qiagen statement said.

Garrigues acts for Qiagen on €118m STAT-Dx acquisition

Ben Cook

Iberian Lawyer, is a monthly digital magazine, published by LC Publishing, available in Spanish and English. It represents the main source of information in the legal business sector in Spain and Portugal. The digital magazine – and its portal – address to the protagonists of law firms and in-house lawyers. The magazine is available for free on the website and on Google Play and App Store.

In every issue of the magazine, you will find rankings of lawyers, special report on trends, interviews, information about deals and their advisors.

For further information, please visit the Group’s website

Iberian Legal Group, S.L.
Registered office: C/ Ríos Rosas 44A - 2 G,H 28003 Madrid España

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram